GFS
UTHR icon

GYL Financial Synergies’s United Therapeutics UTHR Stock Holding History

GYL Financial Synergies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$338K Sell
942
-93
-9% -$31.4K 0.03% 281
2024
Q2 		$330K Buy
+1,035
New +$274K 0.03% 284

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GYL Financial Synergies's UTHR Position: Q3 2024 in Review

GYL Financial Synergies reduced its United Therapeutics (UTHR) stake by 9% in Q3 2024, selling an estimated $31.4K and leaving 942 shares worth $338K. The position accounts for 0.03% of the portfolio, ranked #281.

GYL Financial Synergies first reported a position in UTHR in Q2 2024 and has held it in 2 quarters since. 625 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.

  • GYL Financial Synergies held 942 shares of United Therapeutics worth $338K as of Q3 2024.
  • GYL Financial Synergies sold 93 United Therapeutics shares in Q3 2024, an estimated $31.4K.
  • United Therapeutics made up 0.03% of GYL Financial Synergies's portfolio in Q3 2024, its #281 holding.
  • GYL Financial Synergies first reported a position in United Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 625 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.

Based on GYL Financial Synergies's 13F filing for Q3 2024, filed 7 Nov 2024.